Study provides recommendations on European Medicines Agency’s communication on medicines

Author (Corporate)
Series Title
Series Details 31.5.11
Publication Date 31/05/2011
Content Type

A report written by an independent expert, Dr Frederic Bouder, and published in May 2011, highlighted a number of recommendations to help improve the European Medicines Agency's communication on the benefits and risks of medicines. This is one of the commitments described in the Agency's Road map to 2015.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/05/news_detail_001264.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Benefit/risk communication by the European Medicines Agency: A study of influential stakeholders' expectations and attitudes, March 2011 http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/05/WC500106865.pdf
Subject Categories ,
Countries / Regions